Spotlight: the truth about weight loss drugs

This episode of The PJ Pod delves into the concerns over the imminent availability of weekly weight loss injections from community pharmacy.

In this Spotlight episode of The PJ Pod, we talk about the so-called ‘skinny jabs’ that have been heralded as game-changers for weight management.

Wegovy (semaglutide) is due to be launched in the UK imminently and will soon be available from community pharmacies, with large chains already setting up waiting lists for people wanting to get the weekly injection privately.

Nigel Praities, executive editor at The Pharmaceutical Journal, talks with senior features editor Dawn Connelly and freelance health journalist Emma Wilkinson about how these injections work, who is eligible for them and concerns about whether community pharmacies can provide the long-term lifestyle and psychological support needed for weight loss to be successful.

This episode was produced by Geoff Marsh.

Want to hear more from The PJ Pod? Follow us on SpotifyGoogle PodcastsApple Podcasts or other popular podcast platforms to listen to our latest episodes. 

  • To read our feature on whether community pharmacies should be providing weight loss injections, click here;
  • To read our news story on NICE guidance on semaglutide for people with obesity, click here;
  • To read our feature on a new era for weight loss drugs, click here.
Last updated
The Pharmaceutical Journal, PJ, May 2023, Vol 310, No 7973;310(7973)::DOI:10.1211/PJ.2023.1.183774

    Please leave a comment 

    You may also be interested in